Editorial: New Advances in Cardiorenal Syndrome

Front Cardiovasc Med. 2022 Jul 14:9:976846. doi: 10.3389/fcvm.2022.976846. eCollection 2022.

Laurent Calvier^{1

2}, Gábor Kökény^{3

4}, Ernesto Martinez-Martinez^{5

6}

¹ Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX, United States.
² Center for Translational Neurodegeneration Research, University of Texas Southwestern Medical Center, Dallas, TX, United States.
³ Institute of Translational Medicine, Semmelweis University, Budapest, Hungary.
⁴ International Nephrology Research and Training Center, Semmelweis University, Budapest, Hungary.
⁵ Departamento de Fisiología, Facultad de Medicina, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense de Madrid, Madrid, Spain.
⁶ Ciber de Enfermedades Cardiovasculares, Instituto de Salud Carlos III, Madrid, Spain.

No abstract available

Keywords: biomarker; cardiorenal syndrome; cardiovascular system; fibrosis; heart failure; inflammation; kidney failure; mitochondria.

Publication types